NasdaqGM - Delayed Quote
USD
Axsome Therapeutics, Inc. (AXSM)
206.68
-1.67
(-0.80%)
At close: September 4 at 4:00:01 PM EDT
206.68
0.00
(0.00%)
After hours: September 4 at 7:30:03 PM EDT
Trade AXSM on Coinbase
Trading disclosure
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.
Learn moreRecent transactions
Powered by Yahoo ScoutAxsome Therapeutics Increported 4 insider transactions: 2 stock sales totaling $145,017.00and 2 stock conversions with no dollar value. All activity involved a single officer in June 2026.
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| COLEMAN MARK H Director |
Sale | Jun 10, 2026 | 434,245 |
| JACOBSON MARK L Chief Operating Officer |
Conversion of Exercise of derivative security | May 5, 2026 | 0 |
| JEFFS ROGER A Director |
Sale | Jun 11, 2026 | 58,367 |
| MAHONY SUSAN M Director |
Sale | Jun 10, 2026 | 829 |
| MAIZEL ARI Officer |
Conversion of Exercise of derivative security | Apr 22, 2026 | 0 |
| MURDOCK HUNTER R General Counsel |
Conversion of Exercise of derivative security | Jun 23, 2025 | 0 |
| PIZZIE NICK Chief Financial Officer |
Conversion of Exercise of derivative security | Jun 9, 2026 | 43,355 |
| SAAD MARK E Director |
Conversion of Exercise of derivative security | Jun 8, 2026 | 11,731 |
| TABUTEAU HERRIOT Chief Executive Officer |
Conversion of Exercise of derivative security | Aug 6, 2026 | 7,351,730 |
